Behavioral Health EBITDA Multiples (2025 Update)
Behavioral health remains one of the most consistently active segments within U.S. healthcare services M&A. Even as overall deal volume fluctuates across specialties, behavioral health continues to attract significant institutional capital due to rising demand for mental health support, payer-backed utilization trends, and the continued scalability of multi-state outpatient and home-based models.
Investors have expanded their focus across mental health, autism/ABA therapy, substance abuse/medication-assisted treatment (MAT), and intellectual and developmental disability (IDD) services, each of which exhibits distinct valuation dynamics tied to reimbursement stability, regulatory oversight, and infrastructure maturity.
Across all behavioral categories, 2025 multiples have remained stable compared to 2023–2024, with premium outcomes concentrated among scaled, multi-state platforms with accreditation, diversified payer relationships, and strong clinical governance.
2025 Key Multiples:
Platform: 9–15× EBITDA depending on subsegment and scale
Add-On: 3–9× EBITDA
Highest Premiums: autism/ABA and multi-state mental health
Strongest Volume Growth: IDD care and outpatient mental health
2025 Behavioral Health EBITDA Multiples
The following ranges reflect current U.S. private-market benchmarks for platform and add-on transactions, aligned with data from Scope Research and PitchBook.
| Valuation Ranges (EV/EBITDA) | |||
|---|---|---|---|
| Behavioral Health Segment | Platform Multiple | Add-On Multiple | Notes |
| Mental Health / Outpatient Psych | 10–14× | 4–8× | Strong demand tailwinds; multi-state footprints command a premium. |
| Autism / ABA Therapy | 12–15× (scaled platforms) |
5–9× | Behavioral Innovations’ 2024 sale ~15× EBITDA validated upper range. |
| Intellectual & Developmental Disability (IDD) Care | 9–12× | 4–7× | Deal activity rebounded in 2025; 113% YTD increase. |
| Addiction Treatment / MAT | 8–11× | 4–7× | Lower asset-light margins keep multiples below mental health. |
| Behavioral Staffing & Support Services | 8–10× | 4–6× | Soliant Health deal (~9.6×) confirms mid-market pricing. |
Source: works cited combined with guidance from internal bankers, based generally on knowledge and experience. Actual pricing varies with each transaction based on many factors. Intended for educational purposes only and not a guarantee of any outcome.
Market Dynamics Influencing 2025 Multiples
Investor interest in behavioral health has remained durable through 2025 as utilization across mental health, ABA therapy, and IDD services continues to outpace broader healthcare services. Stabilizing reimbursement, multi-state expansion, and renewed mid-market PE activity have helped anchor valuation ranges even as other provider verticals face regulatory and demand headwinds.
1. Stabilizing Volume and Renewed Sponsor Activity
Scope Research reports the behavioral health category averaged ~40 announced deals per quarter, matching 2019 baseline activity with mental health remaining the most active subsegment.
PitchBook confirms behavioral health was one of the few specialties showing steadiness during the broader PPM-driver healthcare services slowdown in 2025.
2. Infrastructure and Accreditation as Key Multipliers
Across behavioral subsegments, the highest valuations tend to go to platforms with:
Multi-state licensure
CARF or Joint Commission accreditation
Centralized RCM and scheduling
Strong utilization and long waitlists
These drivers directly correlate with premium 12–15× ABA and mental health transactions reported by Scope.
3. Favorable Utilization Trends for Provider-Focused Models
PitchBook’s Healthcare Services comps show providers outperforming payers in 2025 (+14% YTD), signaling stronger fundamentals for outpatient care models, including behavioral.
4. Private Equity Preference for Mid-Market Roll-Ups
Bain’s 2025 report emphasizes that mid-market provider roll-ups (dental, behavioral, eye care) consistently outperform larger funds. Behavioral health sits squarely in this category.
Valuation Drivers Across Behavioral Health
Behavioral health valuations consistently hinge on a defined set of operational and clinical factors, with the drivers below often having the greatest influence on where a practice lands within the current 2025 multiple ranges.
| Driver | Impact on Valuation | Key Indicators Buyers Prioritize |
|---|---|---|
| Scale & Multi-State Footprint | Larger platforms command higher multiples due to reduced operational risk, stronger payer leverage, and proven infrastructure. | • ≥ $10M EBITDA • 15–20+ locations • Standardized systems across markets |
| Diversified Payer Mix | Balanced reimbursement improves stability and reduces exposure to Medicaid volatility, especially in mental health and ABA. | • Commercial + Medicaid mix • Multi-payer contracts • Value-based pilots or early risk arrangements |
| Clinical Governance | Strong oversight reduces regulatory and quality-of-care risk, supporting premium pricing for multi-location platforms. | • Credentialing programs • Documented outcomes • Supervisory structure & clinician retention |
| Centralized Operations | Integrated back-office functions create scalability and margin visibility, a key distinction between add-ons and platform-ready groups. | • Centralized RCM • Centralized intake & scheduling • Recruiting infrastructure • Reporting and analytics systems |
Subsector Deep Dive
Each behavioral health subsector exhibits its own valuation profile, shaped by reimbursement stability, regulatory oversight, and operational complexity. Autism therapy, outpatient mental health, addiction treatment, and IDD care continue to trade within distinct multiple bands that reflect both market maturity and investor confidence.
Autism / ABA Therapy
Autism platforms continue to command the highest multiples in behavioral health. The 2024 sale of Behavioral Innovations for ~$300M at ~15× EBITDA illustrates the premium placed on scaled platforms with ~80 locations across multiple states.
Demand remains elevated; platforms with clinical quality programs, low cancellation rates, and centralized intake systems routinely trade at 12–15×.
Mental Health / Outpatient Psychiatry
Outpatient mental health remains the strongest by deal volume. Multiples hold in the 10–14× range for platforms with:
Hybrid in-person + telehealth access
Clinician retention programs
Multi-state payer contracts
State-level Medicaid trends add tailwinds to high-utilization outpatient models.
Intellectual & Developmental Disability (IDD)
One of the fastest-growing transaction categories of 2025, IDD care is on track for a 113% YoY increase in deal count. While revenue cycles are government-dependent, high occupancy and long waitlists support 9–12× valuations.
Addiction Treatment / MAT
More stable but generally lower multiples than mental health due to real estate and staffing intensity.
Typical range: 8–11× for platforms, 4–7× for add-ons. PitchBook shows addiction and senior living sectors consistently at the lower end of EBITDA spreads.
Behavioral Staffing
Staffing-focused behavioral businesses are gaining attention due to shortages in therapy, nursing, and psychology roles. The Soliant Health recap (~9.6× EBITDA) confirms strong mid-market staffing valuations.
Source: works cited combined with guidance from internal bankers, based generally on knowledge and experience. Actual pricing varies with each transaction based on many factors. Intended for educational purposes only and not a guarantee of any outcome.
Preparing for a Premium Valuation
Practices aiming for top-quartile outcomes can strengthen their position by aligning financial, operational, and clinical systems with the standards buyers consistently reward in diligence.
| Focus Area | Actions That Drive Higher Multiples |
|---|---|
| Financial Clarity | Normalize provider comp; remove personal/one-time expenses; document add-backs. |
| Operational Infrastructure | Centralized RCM, call center, staffing, payor contracting. |
| Accreditation | Joint Commission or CARF accreditation materially improves diligence outcomes. |
| Clinical Workforce Stability | Reduced turnover; supervisory frameworks for therapists and techs. |
| Market Density | 5–10 locations in contiguous geographies outperform scattered footprints. |
Requesting a Copy of This Report
FOCUS Investment Banking specializes in maximizing transaction value for healthcare practice owners through our proven quarterback approach to M&A advisory.
If you’d like to learn more about our healthcare investment banking services, you can reach out here.
Sources
- FOCUS Investment Banking – “What is the Value of my Medical Practice?” (Eric Yetter, 2023)
- DueDilio Industry Guide – “Healthcare Business Valuation: Methods, Metrics & Expert Tips” (June 2025)
- Peak Business Valuation – “Medical Practice Valuation Multiples” (June 2025)
- American Health Law Assoc. – “Healthcare Transactions in 2024 – Notable Deals” (Ankura, Apr 2025)
- VMG Health – “A New Buyer in Physician Practice M&A – Strategic Transactions” (Tim Spadaro, Oct 2024)
- TCTMD / JACC – “Private Equity Interest in Cardiology Has Spiked in Recent Years” (Todd Neale, July 2024)
- Helix Health Capital – “EBITDA vs. EBPC: Valuation in Physician Practice Acquisitions” (Kayla Ballesteros, 2023)
- M&A Healthcare Advisors – “Understanding Value Based on EBITDA Multiples” (2023)
- Palladium Business Brokers – “How to Prepare Your Practice for Sale: A Checklist” (Mar 2025)
- Stifel – “HEALTHCARE SERVICES: Market Update February 2025” (Feb 2025)
